Cargando…

Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections

Host-derived “danger-associated molecular patterns” (DAMPs) contribute to innate immune responses and serve as markers of disease progression and severity for inflammatory and infectious diseases. There is accumulating evidence that generation of DAMPs such as oxidized phospholipids and high-mobilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Mira C., Shirey, Kari Ann, Boukhvalova, Marina S., Vogel, Stefanie N., Blanco, Jorge C. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850323/ https://www.ncbi.nlm.nih.gov/pubmed/29535197 http://dx.doi.org/10.1128/mBio.00246-18

Ejemplares similares

Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation
por: Gopalakrishnan, Archana, et al.
Publicado: (2022)

Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury
por: Shirey, Kari Ann, et al.
Publicado: (2021)

Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2
por: Rallabhandi, Prasad, et al.
Publicado: (2012)

Novel Role of Gastric Releasing Peptide (GRP)-Mediated Signaling in the Host Response to Influenza Infection
por: Shirey, Kari Ann, et al.
Publicado: (2018)

Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection
por: Patel, Mira C., et al.
Publicado: (2017)

Inactivation of respiratory syncytial virus by zinc finger reactive compounds
por: Boukhvalova, Marina S, et al.
Publicado: (2010)

TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
por: Perrin-Cocon, Laure, et al.
Publicado: (2017)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
por: Blanco, Jorge C. G., et al.
Publicado: (2018)

Role of the Lipoxygenase Pathway in RSV-induced Alternatively Activated Macrophages Leading to Resolution of Lung Pathology
por: Shirey, Kari Ann, et al.
Publicado: (2013)

Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection
por: Rajagopala, Seesandra V., et al.
Publicado: (2018)

Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus)
por: Patel, Mira C., et al.
Publicado: (2016)

Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission
por: Grigorov, Ilijana, et al.
Publicado: (2023)

Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection
por: Shirey, Kari Ann, et al.
Publicado: (2019)

Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease
por: Shirey, Kari Ann, et al.
Publicado: (2020)

Naturally acquired anti-high mobility group box 1 antibodies during septic shock
por: Sauneuf, B, et al.
Publicado: (2009)

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy
por: Walker, Lauren Elizabeth, et al.
Publicado: (2017)

Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023)

Induction of High Mobility Group Box-1 in vitro and in vivo by Respiratory Syncytial Virus
por: Manti, Sara, et al.
Publicado: (2018)

Alzheimer’s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT)
por: Boukhvalova, Marina S., et al.
Publicado: (2023)

Prognostic role of serum high mobility group box 1 concentration in cardiac surgery
por: Kim, Namo, et al.
Publicado: (2020)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2018)

High mobility group box-1 levels in schizophrenia: Potential biomarker of remission phase
por: Yilmaz, Nuryil, et al.
Publicado: (2021)

Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats
por: Blanco, Jorge C. G., et al.
Publicado: (2021)

Elucidating the novel biomarker and therapeutic potentials of High-mobility group box 1 in Subarachnoid hemorrhage: A review
por: Richard, Seidu A.
Publicado: (2019)

Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus
por: Boukhvalova, MS, et al.
Publicado: (2018)

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2012)

Prophylactic antibody treatment and intramuscular immunization reduce infectious human rhinovirus 16 load in the lower respiratory tract of challenged cotton rats
por: Blanco, Jorge C.G., et al.
Publicado: (2014)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

The dual role and therapeutic potential of high-mobility group box 1 in cancer
por: He, Si-Jia, et al.
Publicado: (2017)

Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage
por: Zhou, Yu, et al.
Publicado: (2010)

Serum high-mobility group box-1 protein as a specific marker of severe abdominal injury
por: Sakamoto, Y, et al.
Publicado: (2009)

Second-trimester serum high mobility group box-1 and uterine artery Doppler to predict preeclampsia
por: Wairachpanich, Varangkana, et al.
Publicado: (2022)

CIRCULATING DAMAGE-ASSOCIATED MOLECULAR PATTERNS (DAMPS) AS PROGNOSTIC MARKERS OF DISEASE SEVERITY IN PATIENTS WITH COVID-19 ARDS IN THE ICU
por: ALGHANIM, FAHID, et al.
Publicado: (2022)

High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy
por: El-Asrar, Ahmed M. Abu, et al.
Publicado: (2011)

Novel Strategies for Targeting Innate Immune Responses to Influenza
por: Shirey, Kari Ann, et al.
Publicado: (2016)

Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke
por: Richard, Seidu A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q6htj8i52uvtklrpufjsh6pkkt